A new CSP position was established today on Teva Pharmaceutical Industries Ltd (TEVA). All prices include IB commissions.
Note: This is the second position on TEVA.
| Criteria | Value |
|---|---|
| Dividend Champions Status | Contender |
| Years of Consecutive Dividend Increases | 12 |
| Fair Value Estimate | $58.00 |
| Target Buy Price | $40.60 |
| Target Margin of Safety | 30.00% |
| Actual Buy Price | $35.00 |
| Actual Margin of Safety | 39.66% |
| Date | Stock | Description | Transaction | Status | Stock Investment | Income Generated |
|---|---|---|---|---|---|---|
| 11/23/2011 | TEVA | CSP Margin Used | CSP 100 TEVA @ 35.00 | ($3,500.00) | ||
| 11/23/2011 | TEVA | Initial Put Option | STO 1 Jan12 35.00 Put @ 1.01 | $100.98 |
Position Summary
| Cost Basis | ($3,500.00) |
| Income Generated | $100.98 |
| Percent Income Generated | 2.89% |
| Annualized Income Generated | 18.16% |
| Net Profit If Assigned | $100.98 |
| Percent Return If Assigned | 2.89% |
| Annualized Return If Assigned | 18.16% |
| Days Held to Expiration | 58 days |
